Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Capecitabine in Relapsed or Metastatic Head and Neck Cancer
NCT00448552Phase 2Completed
- Sponsor
- University of Miami
- Start
- Feb 2004
- Primary completion
- Apr 2007
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in head and neck cancer (HNC), sponsored by University of Miami. Started Feb 2004; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00448552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448552.